Found 4 results
Filters: Author is Shevlin, Enda  [Clear All Filters]
2020
Gray KD, McCloskey JE, Vedvyas Y, Kalloo OR, Eshaky SEl, Yang Y, Shevlin E, Zaman M, Ullmann TM, Liang H et al..  2020.  PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer.. Clin Cancer Res. 26(22):6003-6016.
2017
Min IM, Shevlin E, Vedvyas Y, Zaman M, Wyrwas B, Scognamiglio T, Moore MD, Wang W, Park S, Park S et al..  2017.  CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.. Clin Cancer Res. 23(24):7569-7583.
Park S, Shevlin E, Vedvyas Y, Zaman M, Park S, Hsu Y-MS, Min IM, Jin MM.  2017.  Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity.. Sci Rep. 7(1):14366.
2016
Vedvyas Y, Shevlin E, Zaman M, Min IM, Amor-Coarasa A, Park S, Park S, Kwon K-W, Smith T, Luo Y et al..  2016.  Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.. JCI Insight. 1(19):e90064.